Clinical Trials on Systemic Sclerosis With Lung Involvement in Finland
Total 624 results
-
Turku University HospitalActive, not recruitingMultiple SclerosisFinland
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFinland
-
Turku University HospitalCompletedMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingFinland
-
Turku University HospitalEnrolling by invitationMultiple SclerosisFinland
-
Turku University HospitalKuopio University HospitalEnrolling by invitationSystemic SclerosisFinland
-
Kuopio University HospitalCompletedRelapse-remitting Multiple SclerosisFinland
-
Turku University HospitalCompletedMultiple SclerosisFinland
-
University of TurkuUnknownColecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)Multiple SclerosisFinland
-
BayerNovartis Pharmaceuticals; Biogen; EPID Research; Merck Serono Europe LtdCompleted
-
VTT Technical Research Centre of FinlandSocial Insurance Institution, Finland; Finnish Institute for Health and Welfare and other collaboratorsCompletedIndividuals With a Disease of Cardiovascular SystemFinland
-
BayerBiogen Netherlands B.V; Novartis Europharm Limited; Merck Europe B.V.Not yet recruitingMultiple Sclerosis (MS)Sweden, Finland
-
Turku University HospitalActive, not recruitingMultiple SclerosisFinland
-
University of Eastern FinlandCompletedQuality of Life | Fatigue | Physical Activity | Relapsing Remitting Multiple SclerosisFinland
-
Turku University HospitalActive, not recruiting
-
Finnish MS SocietySeinajoki Central Hospital; Social Insurance Institution, Finland; Tampere University...Completed
-
Turku University HospitalRecruiting
-
Peili Vision Ltd.RecruitingAttention Deficit Disorder With HyperactivityFinland
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
Vesa LahdesRecruitingHearing Loss | Otitis Media With Effusion | TympanostomyFinland
-
BayerCompletedMultiple SclerosisGermany, Austria, United Kingdom, Israel, Belgium, Finland
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisBelgium, Bulgaria, Canada, Croatia, Czech Republic, Finland, Germany, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Turkey, Ukraine, United Kingdom
-
AstraZenecaCompletedComparing Hospitalisation Time With Seroquel and Seroquel ProlongFinland
-
GlaxoSmithKlineRecruitingScleroderma, Systemic | Systemic Sclerosis Associated Interstitial Lung DiseaseUnited States, Australia, France, Italy, Japan, Spain, Belgium, Greece, Korea, Republic of, China, Mexico, United Kingdom, Finland, Israel, Germany, Argentina, Brazil, Canada, Denmark
-
Eli Lilly and CompanyBioMS Technology Corp.CompletedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Germany, Latvia, Netherlands, Spain, Sweden, United Kingdom
-
NovartisCompletedRelapsing Multiple SclerosisBelgium, Poland, Spain, France, United Kingdom, Guatemala, Canada, Finland, Switzerland
-
Novartis PharmaceuticalsCompletedRelapsing Multiple ScelrosisUnited States, Austria, Belgium, Croatia, Germany, Taiwan, Canada, Czechia, Spain, Argentina, Australia, Peru, South Africa, United Kingdom, Bulgaria, Latvia, Lithuania, Russian Federation, India, Portugal, Italy, Turkey, Finland, France and more
-
US Department of Veterans AffairsCompletedMS (Multiple Sclerosis)United States
-
Eli Lilly and CompanyBioMS Technology Corp.TerminatedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Latvia, Spain, Sweden, United Kingdom, Germany, Netherlands
-
Kuopio University HospitalCompleted
-
SanofiCompletedMultiple SclerosisUnited States, France, Canada, Germany, Spain, Finland, Norway
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisCroatia, Bulgaria, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Poland, Belgium, Hungary, Serbia, Finland, Ukraine, Switzerland, Canada, Turkey
-
US Department of Veterans AffairsTerminated
-
US Department of Veterans AffairsCompletedMultiple SclerosisUnited States
-
Helsinki University Central HospitalRecruitingChronic Rhinosinusitis With Nasal Polyps | Asthma, Aspirin-InducedFinland
-
BayerCompletedMultiple SclerosisSwitzerland, Poland, France, Germany, Hungary, Spain, Sweden, Austria, Czech Republic, Italy, Slovenia, Israel, Belgium, Denmark, Netherlands, Canada, Norway, Finland
-
Merja NikulaHelsinki University Central Hospital; University of Helsinki; University of Oulu and other collaboratorsRecruitingAttention Deficit Hyperactivity DisorderFinland
-
Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisGermany, Estonia, Latvia, Lithuania, Finland, Austria, Denmark, Netherlands, Portugal, Switzerland, Norway, Italy
-
Abbott Diabetes CareRecruitingType 2 Diabetes Treated With InsulinFinland
-
US Department of Veterans AffairsTerminated
-
AstraZenecaTerminatedSubjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GCFinland
-
Helsinki University Central HospitalIda Montini foundation, www.tb-foundation.orgCompleted
-
University of TurkuJuselius Foundation, Helsinki, Finland; Foundation for Paediatric Research,... and other collaboratorsUnknown
-
Novartis PharmaceuticalsRecruitingAmyotrophic Lateral SclerosisAustralia, United States, Finland, Sweden
-
US Department of Veterans AffairsNew York State Department of HealthCompletedALS (Amyotrophic Lateral Sclerosis)United States
-
Angela Taber MDBayer; The Miriam Hospital; Rhode Island HospitalCompletedNon Small Cell Lung Cancer With Bone MetastatsesUnited States
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompleted
-
Novartis PharmaceuticalsTerminatedRelapsing Remitting Multiple Sclerosis (RRMS)Germany, Spain, Australia, Israel, Switzerland, Italy, Austria, Greece, Hungary, Czech Republic, Finland